Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.745 USD | +3.25% | -3.85% | -22.22% |
21/03 | Stifel Cuts Price Target on Vor Biopharma to $12 From $15, Maintains Buy Rating | MT |
21/03 | Oppenheimer Cuts Vor Biopharma Price Target to $15 From $18, Maintains Outperform Rating | MT |
- Stock Market
- Equities
- VOR Stock
- News Vor Biopharma Inc.